ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 2814

Methionine Commits Immunometabolism and Epigenetic Regulation of BACH2 Loci in B Cells, Resulting in Biases Toward Plasmablast Differentiation in the Pathogenesis of SLE

Mingzeng Zhang1, Shigeru Iwata 1, Maiko Hajime 1, Naoaki Ohkubo 1, Yasuyuki Todoroki 2, Hiroko Miyata 2, Jie Fan 2, Shingo Nakayamada 1, Kaoru Yamagata 1 and Yoshiya Tanaka 3, 1The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan, Kitakyushu, Japan, 2The First Department of Internal Medicine, University of Occupational & Environmental Health Kitakyushu, Japan, Kitakyushu, Japan, 3University of Occupational and Environmental Health Japan, Kitakyushu, Japan

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: amino acid and plasmablast differentiation, B cells, Metabolism, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Tuesday, November 12, 2019

Session Title: 5T115: SLE – Etiology & Pathogenesis I: Signaling Pathways (2810–2815)

Session Type: ACR Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Amino acids play an important role in various metabolic processes. However, the role of amino acid metabolism in the regulation of human B cell function remains elusive. To determine the role of essential amino acids in human B cell differentiation and relevance to the pathogenesis of SLE.

Methods:  In the in vitro arm of the study, purified CD19+B cells from healthy donors were cultured withTLR7/9 ligand (LOX or CpG),IFN-α and B cell receptor (BCR) cross-linking, in the presence or absence of amino acids. We determined 1) the types of amino acids that are important for PB differentiation, 2) the amino acid transporters that are important for PB differentiation, 3) the main signaling pathway(s) involved in the presence of amino acids, 4) the transcriptional factors used in the presence of amino acids. In the clinical arm of the study, peripheral blood mononuclear cells (PBMCs) were obtained from 24 patients with RA, 35 patients with SLE, and 21 age-matched healthy controls, and subjected to flow cytometric analysis to determine the expression of amino acids-related markers.

Results:  1) Stimulation with the combination of BCR, IFN-α and TLR7/9 ligand induced PB differentiation accompanied by uptake of amino acids. PB differentiation was abrogated in the absence of essential amino acid methionine, and to a lesser extent leucine, but not in non-essential amino acid cystine. 2) LAT1 and CD98 are known amino acid transporters. The process of plasmablast differentiation encompassed a trade-off balance between upregulation of CD98 and downregulation of LAT1. 3) BCR and mTORC1 signals were susceptible to methionine, while mTORC1 signals were susceptible to leucine. In the presence of methionine, activation of Syk and mTORC1 signals synergistically induced methyltransferase EZH2 expression. EZH2 induced H3K27me3 at BACH2 loci and suppressed BACH2 expression, leading to induction of BLIMP1, XBP1 expression, and plasmablast differentiation. 4)Assessment of the expression of amino acid transporters CD98, LAT1 and EZH2 in B cells in RA and SLE patients showed overexpression of CD98 and EZH2, but not LAT1, in SLE, compared with RA and control. In SLE patients, EZH2 expression level correlated with that of CD98 in B cells. EZH2 expression also correlated with disease activity scores, such as of SLEDAI and BILAG and anti-dsDNA antibodies in patients with SLE.

Conclusion: The results indicate that methionine activates signaling by controlling immunological metabolism in B cells and plays an important role in differentiation of B cells to plasmablasts through epigenome modification through the induction of EZH2, suggesting that methionine is closely related to the pathogenesis of SLE.


Disclosure: M. Zhang, None; S. Iwata, None; M. Hajime, None; N. Ohkubo, None; Y. Todoroki, None; H. Miyata, None; J. Fan, None; S. Nakayamada, Bristol Myers, Sanofi, Abbvie, Eisai, Eli Lilly, Chugai, Pfizer, 8; K. Yamagata, None; Y. Tanaka, Abbvie, 8, AbbVie, 5, 8, Asahi-kasei, 2, Asahi-Kasei, 2, Asahi-kasei, BMS, Chugai, Daiichi-Sankyo, Eisai, Mitsubishi-Tanabe, Ono, Pfizer, Sanofi, Takeda, UCB, 2, Astellas, 8, Astellas Pharma, 9, Astellas Pharma, Inc., 2, 3, 5, 8, 9, Astellas, BMS, Chugai, Daiichi-Sankyo, Eli Lilly, Janssen, Mitsubishi-Tanabe, Pfizer, Sanofic, UCB, YL Biologics, 8, BMS, 2, 5, 8, Bristol-Myers, 2, 8, Bristol-Myers Squibb, 2, 8, Chugai, 2, 8, Daiichi-Sankyo, 2, 8, Daiichi-Sankyo, Astellas, Eli Lilly, Chugai, Sanofi, Abbvie, Pfizer, YL Biologics, Bristol-Myers, 8, Eisai, 2, 8, Eli Lilly, 5, 8, Eli Lilly and Company, 8, Genzyme, 5, Glaxo-Smithkline, UCB, Mitsubishi-Tanabe, Novartis, Eisai, Takeda, Janssen, Asahi-kasei, 8, Janssen, 8, Mitsubishi-Tanabe, 2, 8, Mitsubishi-Tanabe, Bristol-Myers, Eisai, Chugai, Takeda, Abbvie, Astellas, Daiichi-Sankyo, Ono, MSD, Taisho-Toyama., 2, Mitsubishi-Tanabe, Takeda, Daiichi-Sankyo, Chugai, Bristol-Myers, MSD, Astellas, Abbvie, Eisai, 2, Novartis, 8, Ono, 2, Pfizer, 5, 8, Pfizer Inc, 8, Roche, 5, Sanofi, 2, Takeda, 2, 8, Teijin, 8, UCB, 2, YL Biologics, 8.

To cite this abstract in AMA style:

Zhang M, Iwata S, Hajime M, Ohkubo N, Todoroki Y, Miyata H, Fan J, Nakayamada S, Yamagata K, Tanaka Y. Methionine Commits Immunometabolism and Epigenetic Regulation of BACH2 Loci in B Cells, Resulting in Biases Toward Plasmablast Differentiation in the Pathogenesis of SLE [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/methionine-commits-immunometabolism-and-epigenetic-regulation-of-bach2-loci-in-b-cells-resulting-in-biases-toward-plasmablast-differentiation-in-the-pathogenesis-of-sle/. Accessed April 17, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/methionine-commits-immunometabolism-and-epigenetic-regulation-of-bach2-loci-in-b-cells-resulting-in-biases-toward-plasmablast-differentiation-in-the-pathogenesis-of-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.